Qiagen Launches GeneReader NGS System at AMP; Presents Performance Evaluation by Broad | GenomeWeb

This article has been updated with information from Qiagen's website and from its workshop at the AMP annual meeting.

NEW YORK (GenomeWeb) – Qiagen today launched its long-awaited GeneReader next-generation sequencing system, along with a 12-gene cancer panel, at the Association for Molecular Pathology annual meeting in Austin, Texas.

The firm also presented results from an evaluation study by the Broad Institute that compared results from the GeneReader with those from existing clinical assays and other sequencing platforms.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

Sponsored by
Agilent Technologies

In this online seminar, speakers from the Center for Personalized Diagnostics at Penn Medicine will discuss the design and technical validation of a custom next-generation sequencing panel to detect mutations in a wide array of tumor types.